Mitogen-activated protein (MAP) kinases are important players in signal transduction pathways activated by a range of stimuli and mediate a number of physiological and pathological changes in cell function. MAP kinase activation requires phosphorylation on a threonine and tyrosine residue located within the activation loop of kinase subdomain VIII. This process is reversible even in the continued presence of activating stimuli, indicating that protein phosphatases provide an important mechanism for MAP kinase control. Dual specificity phosphatases (DSPs) are an emerging subclass of the protein tyrosine phosphatase (PTP) gene superfamily, which appears to be selective for dephosphorylating the critical phosphothreonine and phosphotyrosine residues within MAP kinases. Some DSPs are localized to different subcellular compartments and moreover, certain family members appear highly selective for inactivating distinct MAP kinase isoforms. This enzymatic specificity is due in part to powerful catalytic activation of the DSP phosphatase after tight binding of its amino-terminal to the target MAP kinase. DSP gene expression is induced strongly by various growth factors and/or cellular stresses, providing a sophisticated transcriptional mechanism for targeted inactivation of selected MAP kinase activities.-Camps, M., Nichols, A., Arkinstall, S. Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J. 14, 6 -16 (1999) 
Protein phosphorylation on serine, threonine, or tyrosine residues has emerged as a critically important posttranslational modification at the heart of regulatory mechanisms controlling cell activities. Levels of protein phosphorylation are dictated by the coordinated activities of protein kinases and protein phosphatases, and the large number of genes encoding these enzymes testifies to their fundamental importance in the control of normal cell and body physiology. In Caenorhabditis elegans, for example, 2.2% of all genes encode protein kinases while ϳ0.5% appear to be protein tyrosine phosphatases (PTPs) (1) . A similar proportion of genes are also committed to direct control of protein phosphorylation in the budding yeast Saccharomyces cerevisiae (1.9% of all genes are protein kinases and 0.23% are PTPs) (2) . Extrapolation from these organisms predicts that the human genome may encode 2000 protein kinases and up to 500 PTPs, providing a complex diversity of enzymes for controlling protein phosphorylation and orchestrating essential changes in cell function.
MAMMALIAN MITOGEN-ACTIVATED PROTEIN KINASES
Mammalian protein kinases fall into two major families that phosphorylate either serine and/or threonine residues (serine/threonine kinases) or tyrosine residues (tyrosine kinases). One major role for cellular kinases is their participation in signal transduction pathways through which cells respond functionally to external messages or to extracellular stresses. Among these, a specialized family of serine/threonine mitogen-activated protein (MAP) kinases are activated by a range of diverse stimuli (3) (4) (5) (6) ). These display a high level of evolutionary conservation and are essential for many cell functions throughout the animal kingdom. These include mating in yeast, morphogenesis in slime mold, vulval development in worms, eye development in flies, mesoderm induction in frogs, as well as lymphocyte differentiation and neuronal death in mammals (5, (7) (8) (9) (10) . Extracellular signal-regulated kinase-1 (ERK1) and ERK2, also known as p44 and p42 MAP kinases, represent the prototypical MAP kinases in mammalian cells. ERK MAP kinase catalytic activation requires phosphorylation by an upstream dual specificity MAP kinase/ERK kinase (MEK) exemplified by MEK-1, which in turn is phosphorylated and activated by a MAP kinase kinase kinase of the Raf family. Of these, c-Raf-1 has been studied extensively and found to undergo activation at the plasma membrane after binding to the GTP-bound form of the low molecular weight G-protein p21ras (3) (4) (5) (6) . In all, four mammalian MAP kinase cascades are currently recognized that, in addition to ERK, include c-Jun NH 2 -terminal kinase/stress-activated protein kinase (JNK/SAPK), p38/RK/CSBP (p38), and big mitogen-activated protein kinase-1/ERK5 (BMK-1/ ERK5) pathways (3) (4) (5) (6) 11) . As with ERK, these MAP kinases are activated by phosphorylation that occurs at a specific threonine and tyrosine residue localized within the activation loop motif TxY of kinase subdomain VIII (where x represents glutamate in ERK, proline in JNK/SAPK, and glycine in p38 MAP kinases). Multiple genes and splice variants for each MAP kinase as well as a number of specific upstream activating kinases responsible for MAP kinase phosphorylation and activation have been identified; these are illustrated in Fig. 1 .
Different cell stimuli activate preferentially distinct MAP kinases. Hence, many growth factor and Gprotein linked receptors, cell adhesion, phorbol esters, and some oncogenes are linked to activation of the ERKs, whereas inflammatory cytokines, trophic factor deprivation, and a number of cell stresses lead preferentially to activation of JNK/SAPK and p38 MAP kinases (3) (4) (5) (6) . Less is known about BMK-1/ERK5 responsiveness, although this MAP kinase has been reported to respond to both growth factors and stressful stimuli (11) (Fig. 1) . MAP kinases target several substrate proteins for phosphorylation, including additional 'downstream' serine/threonine kinases (which themselves become activated), cytoskeletal elements, regulators of cell death, as well as a number of nuclear receptors and transcription factors (Fig. 1) . Such an array of substrates suggests a key role for MAP kinases in controlling diverse cell functions; recent studies using chemical inhibitors and dominant inhibitory or active mutant kinases, as well as analysis of mice after gene deletion, support this. For example, ERK MAP kinases are involved in cellular chemotaxis, cell cycle progression and mitogenesis, oncogenic transformation and metastasis, neuronal differentiation and survival, and in processes underlying memory and learning (3) (4) (5) (6) (12) (13) (14) (15) (16) (17) (18) (19) . One recent study suggests that BMK-1/ERK5 can also participate in pathways leading to cell cycle progression and proliferation (11) . Conversely, JNK/SAPK and p38 MAP kinases are important in pathways controlling T cell differentiation, production of inflammatory cytokines and eicosanoids, and apoptotic cell death (3, 8 -10, 19 -24) . These observations indicate that mechanisms controlling MAP kinases activation state are of critical importance to several diverse aspects of normal and pathological cell functions. In this regard, studies over recent years have provided clear evidence for important and specific roles for upstream kinases in phosphorylating and activating MAP kinases in response to extracellular stimuli (3) (4) (5) (6) (Fig. 1) . In addition to stimulatory input from such MAP kinase kinases, however, activation of MAP kinase is a reversible process even in the continued presence of activating stimuli, indicating that protein phosphatases are also likely to provide an important mechanism for control. Mammalian MAP kinase cascades. Schematic representation of mammalian MAP kinase signal transduction pathways. MAP kinases are boxed together and include the extracellular signal-regulated kinase (ERK), c-Jun NH 2 -terminal kinase (JNK)/stress-activated protein kinase (SAPK), p38, and big MAP kinase-1 (BMK1)/ERK5 subfamilies. Each MAP kinase is activated after phosphorylation by specific upstream MAP kinase kinases as indicated by the solid arrows. MAP/ ERK kinase-1 (MEK1) and MEK2 activate the ERKs, JNK kinase-1 (JNKK1) and JNKK2 activate JNKs, MAP kinase kinase-3 (MKK3) and MKK6 activate the p38's, whereas MEK5 activates BMK1/ERK5. For several MAP kinase and MAP kinase kinase genes, several alternative splice variants have been reported. MAP kinase activation by many diverse stimuli has been reported. Generally, ERKs are activated strongly by polypeptide growth factors as well as by tumor-promoting phorbol esters and some oncogenes. By contrast, JNK and p38 MAP kinases are activated by cell stresses (e.g., UV light, DNA damaging agents, oxidants, osmotic and heat shock), cytokines, tumor necrosis factor-␣, Fas, T cell receptor (TCR)/CD28 costimulation, CD40 ligation, and microbial lipopolysaccharide (LPS). Factors stimulating BMK1/ERK5 are unclear although activation by epidermal growth factor (EGF), serum, hyperosmolarity, and oxidative stress has been reported. MAP kinases phosphorylate serine or threonine residues preceding a proline, although additional docking sites outside of the kinase active site also appear to be important in defining substrate selectivity. Some established target substrates for MAP kinases include the transcription factors Elk-1, SAP-1, c-Jun, MEF-2C, CHOP and PPAR␥, the microtubule regulator stathmin, cytosolic phospholipase A2 (cPLA2), as well as the downstream target kinases MAP kinase-activated protein kinase-1 (MAPKAP-K1, also known as ribosomal p90 S6 kinase or RSK), mitogen-and stress-activated protein kinase-1 (MSK-1), MAPKAP-K2, MAPKAP-K3, MAP kinase-integrating kinase-1 (Mnk1), and Mnk2. MAP kinase kinase activation (broken arrows) is mediated by numerous upstream kinases acting together with various GTP binding proteins as well as complex-forming adaptor proteins (3) (4) (5) (6) .
MAP KINASE INACTIVATION BY THREONINE OR TYROSINE DEPHOSPHORYLATION
Dephosphorylation of either the threonine or tyrosine residue within the MAP kinase activation loop TxY motif alone can result in their enzymatic inactivation. In intact cells, dephosphorylation and inactivation of MAP kinases occur, with kinetics ranging from minutes to several hours depending on the cell type and activating stimulus. In endothelial cells, for example, exposure to serum leads to ERK activation that is sustained at high levels for over 2 h. In contrast, different patterns can be observed in the pheochromocytoma PC12 cell line where EGF-stimulated ERK activation is transient, with inactivation initiated within 5 min and nearly complete within 15-30 min, whereas this MAP kinase displays prolonged activation over several hours on stimulation with NGF (25) . It is believed that different temporal patterns of ERK MAP kinase activation elicited by EGF and NGF underlie their differential effects to drive either cellular proliferation or differentiation, respectively (6) . Using PC12 cells as a model system to identify key phosphatases suppressing ERK activation, biochemical studies revealed that early rapid inactivation of these MAP kinases reflects, in part, threonine dephosphorylation by the PPP serine/ threonine protein phosphatase PP2A (25) (Fig. 2) . In addition to threonine dephosphorylation, these studies also indicated that tyrosine-specific protein phosphatases (PTPs) also contribute to ERK MAP kinase inactivation (25) . Currently, 50 or more PTPs have been characterized (26 -28) , and although the PC12 cell PTPs were not identified molecularly (25) , recent studies in other cell types have identified a possible role for three related PTP gene family members. Hence, PTP-SL (also known as PCPTP1) and STEP are two homologous neuronal PTPs existing in both transmembrane and cytosolic forms that bind tightly as well as dephosphorylate and inactivate ERKs (29) . HePTP (same as LC-PTP) is an additional cytosolic PTP present in lymphoid tissue also reported recently to bind and inactivate this class of MAP kinase (30) (Fig. 2) . PTP-SL, STEP, and HePTP appear to act as functional homologues of the tyrosine-specific PTPs Ptp2 and Ptp3 as well as Pyp1 and Pyp2, identified genetically as down-regulators of MAP kinases in budding and fission yeast, respectively (31) (32) (33) (34) .
Notwithstanding the importance of these early reports on PP2A and tyrosine-specific PTPs inactivating ERKs, little is known of their general importance in terminating MAP kinase signaling, of the molecular mechanisms that may control their phosphatase catalytic activity, or of their specificity for inactivating different MAP kinase isoforms. In contrast to these protein phosphatase classes, there has been significant and rapid progress in our understanding of the role played by a subclass of PTP that possess activity for dephosphorylating both phosphotyrosine and phosphothreonine residues, hereafter termed dual specificity phosphatases (DSPs). It is our current understanding of MAP kinase control by DSPs that is the focus of this review.
THE DSP FAMILY
The prototypical DSP is the VH1 gene identified in 1991 as an open reading frame in vaccinia virus expressed in late-stage viral infection (35) . In 1992, the first mammalian DSP was identified as the mouse immediate early gene 3CH134 (later also cloned as Erp) or its human orthologue CL100, which is induced rapidly after exposure to growth factors, heat shock, or oxidative stress (36 -38) . Sequence homology with VH1 suggested that CL100/3CH134 was a tyrosine phosphatase and this was confirmed after its expression in bacteria. Recombinant CL100/3CH134 was also shown to dephosphorylate threonine and tyrosine residues of ERK MAP kinases, and this was paralleled by kinase inactivation. These studies showed that CL100/3CH134 was specific for dephosphorylation of ERK MAP kinases when compared to a number of other unrelated phosphoproteins (36, 39 -41) . In mammalian cells, a correlation Cell stimulation by a range of growth factors, cell adhesion, and some oncogenes leads to ERK MAP kinase activation triggered by phosphorylation on a threonine and a tyrosine residue localized within the activation loop motif TxY of kinase subdomain VIII. The broken arrow represents upstream kinases within the MAP kinase cascade. Recent studies indicate that ERKs can undergo rapid inactivation by constitutive serine/threonine protein phosphatases such as the PPP family member PP2A (25) . Members of the tyrosine-specific protein tyrosine phosphatase (PTP) gene family exemplified by PTP-SL, STEP, and HePTP also bind and inactivate ERK MAP kinases (29, 30) . Dephosphorylation of either threonine or tyrosine residues results in complete inactivation of the target ERK.
between 3CH134 levels and ERK inactivation suggested specificity for inactivation of MAP kinases, leading to its renaming as MAP kinase phosphatase-1 (MKP-1) (42) .
Despite this important early work, it is now unclear whether CL100/MKP-1 is a physiological regulator of the ERKs rather than other subclasses of MAP kinase. First, we now recognize that MKP-1 is at least as effective in inactivating JNK/SAPK and p38 when compared to ERK MAP kinases (43, 44) . Second, ERK activity is apparently normal after deletion of the CL100/MKP-1 gene in mice (45) . Third, newly identified members of the DSP gene family appear highly selective for ERK and may represent the true physiological regulators of this MAP kinase isoform (see below).
Since the initial cloning of CL100/MKP-1, eight additional mammalian DSP gene family members have been identified and characterized. These include PAC1 (46, 47) , hVH-2/MKP-2 (also cloned as TYP-1) (48 -50), hVH3/B23 (51, 52), hVH-5 (human orthologue of M3/6) (53, 54), MKP-3/PYST1 (same as rVH6) (55-57), B59 (full-length clone of PYST2 and human orthologue of MKP-X) (56 -58), MKP-4 (59), and MKP-5 (60) (Fig. 3) . These DSPs all appear to be effective in mediating inactivation of MAP kinases. VHR is an additional mammalian homologue of VH1 (61), but it lacks an amino-terminal extension identified in all other DSP gene products that is now known to be important for targeting specific MAP kinase substrates (see below). VHR also dephosphorylates growth factor receptor tyrosine kinases and appears to be relatively inactivate against MAP kinases (58, 61) . For these reasons, we consider VHR to represent a distinct DSP subclass and so it is not considered further here.
WHERE ARE DSPs EXPRESSED?
In studies of DSP expression, some gene family members have been found to be restricted to a subset of tissue types. These include PAC1, which is enriched in hematopoietic cells, hVH-5, which is expressed predominantly in brain, heart and skeletal muscle, MKP-5, which is detected only in liver and skeletal muscle, and MKP-4, which was found only in the placenta, kidney, and embryonic liver (46, 47, 53, 54, 59, 60) (Table 1 ). Other DSPs also reveal a restricted expression pattern when studied by in situ analysis. For instance, although Northern blotting reveals that CL100/MKP-1, B29 (MKP-X), MKP-3/ PYST1, and hVH-3/B23 are all present in adult rat brain, more detailed analysis in brain slices demonstrates a highly localized and distinct expression pattern for these DSP gene family members (62) . In addition, DSPs can also occupy distinct subcellular compartments. Hence, whereas CL100/MKP-1, PAC-1, hVH-2/MKP-2, and hVH-3/B23 are all localized within the nucleus, MKP-3/PYST1 appears to be exclusively cytosolic (46, 48, 51, 56, 57) . MKP-4, in contrast, is present in cytosol as well as in punctate nuclear bodies colocalizing with the promyelocytic protein (59) . Other DSPs are different, again as illustrated by M3/6, which may be either nuclear or cytosolic depending on its cellular environment (54) .
TRANSCRIPTIONAL CONTROL OF DSPs
Another interesting feature of DSPs is their tight and rapid transcriptional induction by growth factors and/or cellular stresses. Indeed, CL100/MKP-1 was identified originally as an immediate early gene induced rapidly within 30 -120 min in cultured cells by mitogens, heat shock, or oxidative stress (36, 37) . Other DSP genes also undergo transcriptional upregulation in cell lines exposed to growth factors and/or cellular stress (summarized in Table 1 ). In some instances, DSP gene induction appears specific for a given stimulus. In PC12 cells, for instance, CL100/MKP-1, hVH-2/MKP-2, and hVH-5 all undergo rapid induction as immediate early genes in response to mitogenic factors whereas MKP-3/PYST1 expression is stimulated exclusively by agents promoting neuronal differentiation, most particularly Figure 3 . Schematic representation of human dual specificity phosphatase (DSP) amino acid sequence homologies. Numbering indicates first and last residue of the amino-and carboxyl-terminal halves of each DSP. The predicted amino acid sequence of these domains was used for independent calculation of percentage sequence identity with the corresponding region of CL100/MKP-1, using the SIM pairwise sequence alignment program. Human sequences used for comparisons were obtained from the GeneBank/EMBL data bases, using the following accession numbers: CL100/MKP1, X68277; hVH2, U21108; hVH3, U16996; hVH5, U27193; PAC1, L11329; MKP-3/PYST1, X93920; B59, X93921; MKP-4, Y08302; MKP-5, AB026436. by NGF (50, 53, 54, 56, 63) . Tight transcriptional control of DSP genes also occurs in vivo as indicated by studies in rats undergoing kainic acid-induced seizure activity where CL100/MKP-1, hVH-3/B23, PAC-1, and MKP-3/PYST1 are all reversibly up-regulated in discrete brain regions. Under these conditions of up-regulation, different DSPs map to distinct brain areas displaying either neuronal plasticity, apoptotic death, or survival (62, 64) . CL100/MKP-1 also displays transient and highly regionalized induction within specific brain regions during normal embryonic development (62) . Mechanisms controlling DSP induction are likely to be complex although expression of some gene family members, including CL100/MKP-1, hVH-2/MKP-2, and PAC1, is reported to be dependent at least in part on MAP kinase activation (65) (66) (67) . This provides clear scope for negative feedback of the inducing MAP kinase or for regulatory cross talk between parallel MAP kinase pathways.
CHROMOSOMAL LOCALIZATION OF DSP GENES
MAP kinases have been implicated in processes underlying cellular transformation, tumor formation, and metastasis (14 -16, 68, 69) . Consistent with 5) and GeneDoc software. At any one position, conservation between DSP gene family members of 100%, Ͼ80% or Ͼ60% is indicated by shading in black, dark gray, and light gray, respectively. B) Sequence alignment of extended active site motif of human CL100/MKP1 with amino acids from potential DSPs encoded by mammalian EST sequences corresponding to the accession numbers shown. Arrows indicate the positions of the active site cysteine and aspartate residues predicted to play an essential role in the catalytic mechanism of DSP hydrolysis. C) Schematic representation of the DSP catalytic mechanism (28). The DSP active site is represented by the diagonal gray box, which shows the catalytic aspartate (Asp) and cysteine (Cys) residues. The phosphotyrosine shown is localized within the MAP kinase activation loop motif TxY of kinase subdomain VIII. For clarity, phosphothreonine is not shown. The phosphatase reaction proceeds in two steps. First, the thiolate anion of cysteine attacks the tyrosine phosphate (1.) and forms a cysteinyl-phosphate intermediate (2.) . Release of tyrosine follows donation of a proton by the aspartic acid acting as a general acid (2.). For the second step of the catalytic reaction, the same aspartate acts as a general base to take a proton from a water molecule, which in turn attacks the phospho-enzyme intermediate to eliminate phosphate and regenerate active DSP enzyme (4.). The phosphothreonine within the MAP kinase TxY motif is probably dephosphorylated by an identical mechanism.
this, expression of CL100/MKP-1, hVH-3/B23, or B59 inhibits oncogene-driven DNA synthesis and cell transformation (58, 70) . With such a potential tumor suppressor role in mind, it is of note that the chromosomal localization of all human DSP genes have now been mapped and several of these occupy regions implicated in genetic reorganizations associated with the incidence of some cancers (38, 54, 59, 71, 72) (Table 1) . MKP-3/PYST1, for instance, is localized to a region of frequent allelic loss in pancreatic cancer (12q21-23) and also displays lower levels of expression in several pancreatic tumor cell lines (73) .
DSP CATALYTIC DOMAIN
Amino acid sequence comparison between DSPs reveals the highest similarity within and immediately around a catalytic active site sequence motif Dx 26 (V/ L)x(V/I)HCxAG(I/V)SRSxT(I/V)xxAY(L/I)M (where x is any amino acid) localized within the carboxyl-terminal half of these enzymes (Fig. 4A) . Screening the EST database reveals at least six additional potential mammalian members of this gene family displaying a conserved DSP catalytic active site (Fig. 3B ). This motif contains at least two residues (underlined) known to be critically important within a two-step catalytic reaction. According to a model of catalysis by PTPs, an essential cysteine functions as an active site nucleophile forming a covalent thiophosphate intermediate, whereas the aspartate acts as a general acid to donate a proton to the leaving group. The same aspartate then probably acts as a general base taking a proton from a water molecule, which then attacks the phospho-enzyme intermediate to eliminate phosphate and regenerate active enzyme (28) (Fig. 3C) . Both threonine and tyrosine residues are likely to be dephosphorylated by the same catalytic mechanism, and the crystal structure of VHR suggests that a shallow active site (as opposed to the deeper cleft of tyrosine-specific PTPs) accounts for the less stringent phosphoamino acid specificity of the DSPs (28).
NATURALLY OCCURRING INACTIVE DSP 'MUTANTS'
In contrast to the DSP active site motif described above, a naturally occurring enzymatically inactive DSP (STYX) has been identified in which the catalytic cysteine is replaced by glycine. The inactive 'catalytic site' of STYX may bind phosphotyrosine in a manner analogous to SH2 and PTB binding domains found within various signal transduction effector targets and adaptor proteins. An additional noncatalytic DSP homologue Sbf1 has also been described recently, and database searching reveals additional sequences such as MK-STYX, which is predicted to encode similarly inactive DSPs (74) . This indicates that STYX could be the prototype of a new subfamily of catalytically inactive DSPs, though their functional significance is currently unclear.
SEQUENCE DIVERGENCE WITHIN THE AMINO-TERMINAL OF DSPs
Whereas the carboxyl-terminal catalytic core of DSPs is well conserved, considerably less sequence homology is evident within the amino-terminal half of these enzymes (Fig. 3) . One role of specific sequences within the amino terminus region could be to define their subcellular localization. Indeed, a potential nuclear localization motif has been suggested within the amino terminus of hVH-3/B23 (52), and similar sequences can also be identified in CL100/MKP-1, hVH-2/MKP-2, and PAC-1. In contrast, putative nuclear export motifs have been proposed within the amino terminus of rVH-6 (MKP-3/PYST1) and B59 (55, 58) . The presence of these motifs is consistent with the subcellular localization reported for these DSPs (see above). Despite sequence divergence within the amino-terminal, all DSPs possess two short stretches of homology containing residues conserved with two segments flanking the active site of the Cdc25 phosphatase. These motifs have been designated CH2 (Cdc25 homology regions) A and B or, alternatively, CH2-N and CH2-C (75, 76). The functional significance of these motifs is currently unknown, although a role for the amino-terminal in binding substrate MAP kinases (see below) could reflect properties associated with one or both CH2 domains. Examination of the gene structures of CL100/MKP-1 and PAC1 (38, 76, 77) indicates that their amino termini may have distinct evolutionary origins to the carboxyl-terminal catalytic core. In fact, of four exons comprising the murine CL100/ MKP-1 gene, exons 1 and 2 encompass the CH2-N and CH2-C domains, respectively, tempting speculation that these exons may have converged with a smaller gene encoding simply a DSP catalytic core.
SELECTIVE MAP KINASE INACTIVATION BY DSPs
One striking development in our understanding of DSP action came with the discovery that some gene family members display specificity for inactivating different MAP kinases. Hence, studies using purified proteins and transfected mammalian cells have revealed that low concentrations of MKP-3/PYST1 completely inactivate ERK1 and ERK2 but not JNK/ SAPK or p38 MAP kinases (57, 78) . This contrasts with another DSP, M3/6, which appears highly specific for inactivating JNK/SAPK and p38 MAP kinases, as even high expression levels failed to inhibit ERK activation by growth factor or oncogenic p21ras (78) . Other DSPs also display selectivity in that MKP-4 is more effective at inactivating ERKs and MKP-1 acts preferentially on JNK/SAPK and p38 MAP kinases, whereas PAC-1 and hVH-2/MKP-2 show limited specificity for ERK and either p38 and JNK/SAPK, respectively (43, 44, 59) (Table 1) . Although this selectivity could reflect merely a substrate preference by the catalytic domains of these different DSPs, it appears that an additional unexpected mechanism accounts at least in part for specific MAP kinase inactivation.
MAP KINASE SELECTIVITY REFLECTS DSP BINDING AND CATALYTIC ACTIVATION
In 1996 a report from Steve Keyse's laboratory demonstrated that MKP-3/PYST1 is able to form a stable complex with ERK MAP kinases (57) . More detailed analysis of this interaction soon revealed that MKP-3/PYST1 binding to ERK MAP kinases was direct and unexpectedly involved the noncatalytic amino terminus of the MKP-3/PYST1 protein. Indeed, when expressed alone, the carboxyl-terminal catalytic domain of MKP-3/PYST1 was devoid of ERK binding activity (79) . Strikingly, when interaction with different MAP kinases was compared, the MKP-3/PYST1 amino terminus was found to bind tightly to both ERK1 and ERK2 but not to JNK3 (SAPK␤), JNK2 (SAPK␣), or p38 MAP kinases (79, 80) . This binding specificity mirrors the selectivity of MKP-3/PYST1 for inactivating different MAP kinases and raised the question of whether amino-terminal substrate binding alters the catalytic activity of this DSP. As indicated by MKP-3/PYST1-dependent hydrolysis of the artificial substrate p-nitrophenyl phosphate (p-NPP), purified ERK2 was found to stimulate the catalytic activity of this DSP by more than 40-fold. This effect was independent of protein kinase activity and required binding of ERK2 to the noncatalytic amino terminus of MKP-3/PYST1. Neither JNK/SAPK nor p38 MAP kinases bound or stimulated significant MKP-3/PYST1 catalytic activity over basal levels (80) . Together, these observations indicate that MKP-3/ PYST1 selectivity for ERK MAP kinases may reflect tight substrate binding through its amino terminus, leading to its catalytic activation and consequent dephosphorylation and inactivation of the bound MAP kinase (Fig. 5) . In support of this, an aminoterminally truncated version of MKP-3/PYST1 devoid of binding activity loses its selectivity for inactivating ERKs and displays similar but reduced activity against all MAP kinases (79, 80). In addition, a mutant form of ERK2 (D319N) analogous to the Drosophila gain-of-function ERK-A mutation sevenmaker is disabled in its ability to either bind or activate MKP-3/PYST1. This may account for its hypersensitivity to activation in vivo as well as its resistance to inactivation by DSPs (43, 80, 81) . Purified MKP-4 (80) and MKP-1 (S. Arkinstall, unpublished observations) also bind and undergo catalytic activation by purified MAP kinases in parallel with their enzymatic selectivity, suggesting that this is a general mechanism for activating DSPs and targeted inactivation of MAP kinases.
MODEL FOR MAP KINASE CONTROL BY DSPs
Together, these observations suggest the following model for MAP kinase inactivation by DSPs (Fig. 6) . Stimulation by growth factors, cytokines, cell stresses, or some active oncogenes leads to rapid transcription of one or a subset of DSP genes. Increased DSP transcription may reflect activation of specific MAP kinases, although alternative pathways are not excluded. After translation of the DSP mRNA into protein, the catalytically inactive DSP translocates to a specific subcellular compartment within either the nucleus or cytosol. Upon encountering its target MAP kinase, the DSP binds tightly through its amino terminus, which in turn triggers activation of the phosphatase catalytic domain. If the bound MAP kinase is already activated, then this will result in its rapid inactivation. Conversely, if the MAP kinase is not active, then its tight interaction with an active DSP is expected to block any possibility of kinase activation by a subsequent stimulus. MAP kinases that fail to bind the DSP within its amino terminus remain active or susceptible to activation after extracellular stimulation. Depending on their cellular localization, these regulatory effects allow for selected inhibition of MAP kinase activities in specific subcellular compartments. Some DSPs have been shown to possess short half-lives (38, 39) , suggesting that in the absence of continued gene transcription and protein synthesis, their rapid turnover limits their duration of action in cells. Overall, tight control of DSP gene induction, combined with their differential binding and catalytic activation by a specific repertoire of MAP kinases, provides a sophisticated mechanism for rapid and targeted inactivation of selected MAP kinase activities.
From a broader perspective, tight binding between DSP family members and MAP kinases represents a further example of an association indicative of higher order complexes within cellular signal transduction pathways. ERK, for example, binds to a number of proteins involved in this MAP kinase cascade. These include the activating kinase MEK-1, the target transcription factors Elk-1, c-Myc and STAT1␣, downstream kinases including the MAP-KAP-K1 (p90 S6 kinase, RSK), Mnk1, and Mnk2, as well as the potential scaffold proteins MP1 and Ksr (82) (83) (84) (85) (86) (87) (88) (89) (90) . Together with the DSP MKP-3/PYST1, these proteins may form stable or dynamic multimolecular complexes similar to those underlying pheromone-stimulated MAP kinase activation in budding yeast (7) . Ordered protein complexes probably play a major role defining specificity of communication within MAP kinase signaling cascades and is an emerging theme also seen in other signal transduction pathways, as exemplified in the multimeric 'signalsome' comprising several essential components required for activation of the transcription factor NF-B (91). Increased expression is likely to reflect activation of transcription factors (black circles) via both MAP kinase-dependent and independent pathways. Newly synthesized DSPs translocate to specific subcellular compartments as dictated by anchorage and/or localization motifs not yet identified. Specific binding to target MAP kinases through regions within the DSP amino terminus then triggers activation of the phosphatase catalytic domain. Bound MAP kinases are in turn inactivated by dephosphorylation on threonine and tyrosine residues localized within the 'activation loop' motif TxY. Inactive MAP kinases then dissociate, leaving the DSP free to bind and inactivate another MAP kinase molecule. In the absence of continued DSP gene transcription and protein synthesis, rapid degradation may limit their duration of activity in cells.
